It appears that CCR10 ligands modulate the effects of hematopoietic growth factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF), and FMS-like tyrosine kinase 3 ligand (FLT3L) on AML cells [114]. The gene discussed is CSF2; the disease is acute myeloid leukemia.